TCRX

TCRX

USD

TScan Therapeutics Inc. Common Stock

$1.120-0.050 (-4.274%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$1.170

高値

$1.250

安値

$1.080

出来高

0.81M

企業ファンダメンタルズ

時価総額

63.6M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.51M

取引所

NGM

通貨

USD

52週レンジ

安値 $1.02現在値 $1.120高値 $6.225

関連ニュース

Analyst Upgrades

BTIG Downgrades TScan Therapeutics to Neutral

BTIG analyst Justin Zelin downgrades TScan Therapeutics from Buy to Neutral.

もっと見る
BTIG Downgrades TScan Therapeutics to Neutral
Analyst Upgrades

Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6

Needham analyst Gil Blum maintains TScan Therapeutics with a Buy and lowers the price target from $9 to $6.

もっと見る
Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6
GlobeNewswire

TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027

Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to prioritize heme development;

もっと見る
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。